公开(公告)号：US20210261652A1

公开(公告)日：2021-08-26

申请号：US17181997

申请日：2021-02-22

Applicant: PROTHENA BIOSCIENCES LIMITED

Inventor： Tarlochan S. Nijjar ,  Robin BARBOUR ,  Philip James DOLAN, III ,  Yue LIU ,  Svetlana ALEXANDER ,  Mark E. RENZ

IPC: C07K16/18 ,  C12N15/63

Abstract: The invention provides antibodies that specifically bind tau. The antibodies inhibit or delay tau-associated pathologies and associated symptomatic deterioration.

公开(公告)号：US20240309078A1

公开(公告)日：2024-09-19

申请号：US18601222

申请日：2024-03-11

Applicant: Prothena Biosciences Limited

Inventor： Robin BARBOUR ,  Svetlana ALEXANDER ,  Mark E. RENZ ,  Shuning GAI ,  Tarlochan S. NIJJAR ,  Philip James DOLAN, III ,  Philip PAYNE

IPC: C07K16/18

CPC classification number: C07K16/18 ,  C07K2317/24 ,  C07K2317/565 ,  C07K2317/567 ,  C07K2317/76 ,  C07K2317/92

Abstract: The invention provides antibodies that specifically bind tau. The antibodies inhibit or delay tau-associated pathologies and associated symptomatic deterioration.

公开(公告)号：US20220153821A1

公开(公告)日：2022-05-19

申请号：US17291986

申请日：2019-11-08

Applicant: PROTHENA BIOSCIENCES LIMITED

Inventor： Tarlochan S. NIJJAR ,  Robin BARBOUR ,  Philip James DOLAN, III ,  Yue LIU ,  Svetlana ALEXANDER ,  Mark E. RENZ

IPC: C07K16/18 ,  A61K47/68

Abstract: The invention provides antibodies that specifically bind tau. The antibodies inhibit or delay tau-associated pathologies and associated symptomatic deterioration.